Research notes.
A quarterly reading list on peptide pharmacology, compound purity, storage, and what published research actually says. Written for researchers who read primary literature.
Why Peptide Therapy Dominates Longevity Research in 2026
A survey of the 2024–2026 peptide longevity literature — what studies have moved the field, where the research is strongest, and what remains speculative.
Read the dispatch →Why Lyophilized Peptides Are Replacing Pre-Mixed Formats
The format trend moving peptide sourcing away from pre-mixed vials and toward lyophilized powder — stability, purity verification, shelf life.
The Semaglutide-to-Retatrutide Shift: A Researcher's Reading List
Triple-agonist peptides are the next generation beyond semaglutide and tirzepatide. Here's the research timeline, mechanism differences, and what remains unknown.
Epithalon: What the Recent Telomerase Studies Actually Found
A plain-English reading of the 2022–2025 Epithalon studies — what was measured, what was claimed, and what the effect sizes look like in context.
BPC-157 in 2026: New Animal-Model Data, Reviewed
Recent BPC-157 studies on tendon repair, gut permeability, and neurological injury — what the data looks like heading into 2026.